Wallingford, PA, United States of America

Jian Yan

This inventor holds 73 USPTO granted patents and 36 published patent applications, plus 16 CIPO patents and 20 EPO patents, primarily in Cancer Vaccines (CPC class A61K). Top assignees: University of Pennsylvania, Inovio Pharmaceuticals, Inc., The Wistar Institute. Active years: 2012-2026.

USPTO Granted Patents = 73 (Patent Applications = 36)

% Patents Active = 97.3

CIPO Patents = 16 (Patent Applications = 27)

EPO Patents = 20 (Patent Applications = 47)

Average Co-Inventor Count = 3.2

ph-index = 6

Forward Citations = 102(Granted Patents)

Forward Citations (Not Self Cited) = 73(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Haverford, PA (US) (2015 - 2017)
Havertown, PA (US) (2012 - 2020)
Wallingford, PA (US) (2015 - 2024)

Company Filing History:

56 out of 2,651

University of Pennsylvania

patents

47 out of 93

Inovio Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

patents

5. 1 out of 9

The Trustees of the University of Pennslyvania

patents

6. 1 out of 15

The Wistar Institute of Anatomy and Biology

patents

7. 1 out of 18

Vgx Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Cancer Vaccines

Immunotherapeutics

Nucleic Acid Constructs

DNA Antibody Constructs

Filovirus Antigens

Prostate Antigens

Recurrent Respiratory Papillomatosis

Influenza Virus

FMDV Proteins

Optimized Immunogenic Peptides

Interleukin-33 Adjuvant

ZIKV Envelope Antibodies

73 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12679904 - CANCER VACCINES TARGETING SURVIVIN AND USES THEREOF (2026-07-14),

2. 12668616 - WT1 VACCINE (2026-06-30),

3. 12492243 - DNA Antibody Constructs for Use against Pseudomonas Aeruginosa (2025-12-09),

4. 12478667 - Vaccines For Recurrent Respiratory Papillomatosis And Methods Of Using The Same (2025-11-25),

5. 12350318 - Combination therapy to treat brain cancer (2025-07-08),

6. 12285473 - Cancer vaccines targeting MUC16 and uses thereof (2025-04-29),

7. 12240872 - Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same (2025-03-04),

8. 12161706 - Cancer vaccines targeting BORIS and uses thereof (2024-12-10),

9. 12064473 - Cancer vaccines targeting Survivin and uses thereof (2024-08-20),

10. 12049479 - Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom (2024-07-30),

11. 11986517 - Cancer vaccines targeting mesothelin and uses thereof (2024-05-21),

12. 11980659 - Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same (2024-05-14),

13. 11925685 - DNA antibody constructs encoding anti-ZIKV envelope antibodies (2024-03-12),

14. 11865166 - Nucleic acid encoding optimized immunogenic peptide that targets follicle stimulating hormone receptor (2024-01-09),

15. 11851477 - DNA monoclonal antibodies targeting influenza virus (2023-12-26),

Title: The Innovative Journey of Jian Yan

Introduction: Jian Yan, a talented inventor hailing from Wallingford, PA, has made significant contributions to the world of technology and innovation.

Latest Patents: Jian Yan's latest patents showcase his expertise in the field of renewable energy, with a focus on solar panel efficiency and energy storage solutions.

Career Highlights: Throughout his illustrious career, Jian Yan has been at the forefront of cutting-edge technological advancements. His work in developing sustainable solutions has earned him recognition as a pioneer in the industry.

Collaborations: Jian Yan has collaborated with leading research institutions and universities to further his innovative projects. His partnerships have led to groundbreaking discoveries in the realm of clean energy technology.

Conclusion: Jian Yan's dedication to pushing the boundaries of innovation continues to inspire future generations of inventors. His passion for creating a more sustainable world through technology sets him apart as a visionary in the field.